O. Greg Deardorff, PharmD, BCPP
- 7Articles
- 43.2KReads
- 2004–2019Active
- 21Collaborators
- 19Citations
About
O. Greg Deardorff, PharmD, BCPP, has contributed extensively to the fields of psychiatry and psychopharmacology, focusing on conditions such as major depressive disorder, schizophrenia, schizoaffective disorders, and movement disorders including tardive dyskinesia. Deardorff’s publications address clinical management topics like antioxidant treatments for tardive dyskinesia, clozapine-induced myocarditis, serotonin syndrome prophylaxis, and weight management in patients treated with antipsychotics. His work spans from 2004 to 2019 and has appeared in Psychiatrist.com journals.
Publications
Clozapine-Induced Myocarditis: The Heartfelt Silent Assassin
October 11, 2018
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
